Microtubule-associated protein Tau is the major protein subunit of neurofibrillary tangles (NFT), one of the major neuropathological hallmarks of a group of neurodegenerative diseases such as Alzheimer disease (1, 2) . NFTs are mainly composed of bundles of Tau in the form of paired helical filaments (PHF), straight filaments or twisted ribbons (3) . Because the accumulation of Tau aggregates correlates well with nerve cell loss and severity of dementia, formation of NFT is considered to be involved in the pathways leading to neuronal death (4) (5) (6) , and the characterization of factors involved in Tau fibrillization is of great importance to clarify the etiology of such neurodegenerative diseases.
Tau is among one of the largest proteins without recognizable secondary structure and adopts a natively unfolded structure in solution (7) . It binds to microtubules through repeat domain (R1-R4) in their C-terminal part (8) . The repeat domain of Tau forms the core of PHFs in Alzheimer disease and also assembles more readily than full-length Tau into bona fide PHFs in vitro (9, 10) .
To mimic Tau fibrillization in vivo, polyanionic cofactors such as heparin have been used to induce Tau filament formation in vitro (1, (11) (12) (13) (14) . It has been shown that Tau and heparan sulphate (HS) coexists in nerve cells with overt neurofibrillary lesion (12) . The molecular basis for such an inducement process remains unknown. However, the discovery that other polyanions such as RNA (15) or arachidonic acid (16) can also cause Tau filament formation indicates that Tau aggregation is rather influenced by electrostatics than by the precise nature of the negatively charged polymers (17) . The kinetics for inducer mediated Tau filament formation can be characterized by a lag period, followed by a period of exponential growth and an asymptotic approach to equilibrium (13, (18) (19) (20) . The filamentous structures induced by heparin are structurally similar to those found in Alzheimer disease (1) , and thus heparin-induced Tau aggregation serves as a good model for pathological Tau fibrillization.
In the present study, we quantitatively characterized the interaction between recombinant human Tau fragment   Tau 244-372 and heparin as well as  heparin-induced fibril formation of  Tau 244-372 by using several biophysical  methods, such as static light scattering,  isothermal titration calorimetry (ITC),  turbidity assays and transmission  electron microscopy. Our data demonstrated that at physiological pH and temperature, human Tau 244-372 did form 1:1 complex with heparin. Heparin shows a strong binding affinity to Tau in the presence of dithiolthreitol (DTT), triggering Tau fibrillization under such reducing conditions.
EXPERIMENTAL PROCEDURES
Materials -Heparin (average molecular mass = 7 kDa) was obtained from Sigma (Sigma-Aldrich Co, St. Louis, MO). DTT was obtained from Ameresco (Ameresco Chemical Co., Solon, OH). All other chemicals used were made in China and were of analytical grade. All reagent solutions were prepared in 10 mM HEPES buffer (pH 7.4) containing 100 mM NaCl.
Plasmids and Proteins -The cDNA encoding human Tau fragment Tau 244-372 was amplified using the plasmid for human Tau40 (kindly provided by Dr. Michel Goedert) as a template. The PCR-amplified Tau 244-372 was subcloned into pRK172 vector. Recombinant Tau 244-372 was expressed in Escherichia coli and purified to homogeneity by SP sepharose chromatography as described (21) . Purified Tau protein was analyzed by SDS-PAGE with one band. The concentration of human Tau fragment was determined according to its absorbance at 214 nm with a standard calibration curve drawn by bovine serum albumin.
Turbidity Assays -Samples of 160 μM Tau 244-372 were incubated at 37 0 C in 10 mM HEPES buffer (pH 7.4) containing heparin at different concentrations (20-640 μM) and 100 mM NaCl in the presence and absence of 1 mM DTT or in 10 mM HEPES buffer (pH 7.4) containing 160 μM heparin and NaCl at different concentrations (0-500 mM) in the presence of 1 mM DTT. The solutions with a volume of 250 μl were placed into a well of a 96-well plate followed by monitoring the turbidity at 350 nm using a SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA). Each sample was run in triplicate or quadruplicate. The profile of absorbance versus time was analyzed as follows. A seventh order polynomial was fitted to all data {t, A 350 } from replicates at each heparin concentration. The maximum slope of the best-fit polynomial (dP/dt) max , the value of t corresponding to maximum slope of the polynomial t* and the value of the polynomial at this time P(t*) were evaluated. A straight line with slope (dP/dt) max was drawn through {t*, P(t*)}, and the value of t at which this line crosses the t axis (P = 0) is designated the lag time.
Transmission Electron MicroscopyThe formation of filaments by human Tau fragment was confirmed by electron microscopy of negatively stained samples. Sample aliquots of 10 μl were placed on copper grids, and left at room temperature for 1-2 minutes, rinsed with H 2 O twice, and then stained with 2% (w/v) uranyl acetate for another 1-2 minutes. The stained samples were examined using an H-8100 transmission electron microscope (Hitachi, Tokyo, Japan) operating at 100 kV or an FEI Morgagni transmission electron microscope operating at 80 kV.
Isothermal 
Calorimetric data of the 14th injection was integrated of the heat power peak of the reaction.
Composition Gradient-static Light Scattering -Tau 244-372 and heparin were thoroughly dialyzed against 10 mM HEPES buffer (pH 7.4) containing 100 mM NaCl and 1 mM DTT. Immediately before light scattering measurement, both protein and heparin solutions were filtered through a 0.02 μm filter (Anotop 10 Plus, Whatman) and centrifuged at 5000 rpm and These solution mixtures were pumped in sequence into parallel flow cells in which the static light scattering intensity and refractive index of each mixture was measured simultaneously in a DAWN-EOS light scattering photometer (Wyatt) and an Optilab rEX differential refractometer (Wyatt). The raw data obtained from each instrument were respectively converted into values of the normalized scattering intensity R/K opt and f A as described (25, 26 
The experimentally determined dependence of R/K opt upon f A was modeled using Equations (3-7) to calculate the equilibrium values of c A , c B , and c AB , and then using Equation (11) with the values of G A , G B , and G AB given above to calculate R/K opt . The values of M A , M B , and log 10 K AB were allowed to vary to achieve a best fit via nonlinear least squares.
RESULTS

Interaction between Tau and Heparin
Under Reducing Conditions -The experimentally measured dependence of R/K opt on f A is plotted in Fig. 1 Further fibrillization kinetics analyses showed that the lag time appeared to be approximately invariant up to a molar ratio of 2:1, and then got longer at larger ratios of heparin/Tau in the presence of DTT (Fig.  4B) . The maximum slope representing the apparent rate constant for fibril growth increased sharply with substoichiometric ratios of heparin/Tau, and then decreases to some extent with ratios > 1:1 in the presence of DTT (Fig.  4A) .
Heparin Mediated Tau Filament Formation Under Oxidative Conditions
-In order to monitor the fibrillization of Tau 244-372 in the absence of DTT, the 14th injection had an 8-h interval after 13 consecutive injections. The ITC curve of the fibrillization of Tau 244-372 was shown in Fig. 2C . The curve represented heat of the reaction as a function of time by integrating the power change (ΔP) peak of the reaction shown in the inset box, corrected by the reference. This represented the kinetics of the reaction via the enthalpy production, indicating the high accuracy and low noise of the measurement even without smoothing of the data (inset of Fig. 2C ). The calorimetric data between 60-540 min clearly confirmed heparin mediated Tau filament formation under oxidative conditions (Fig.  2C ). Meanwhile the TEM image of Tau aggregates formed in the ITC cell showed typical long and branched fibrils, further confirming the fibrillization of Tau 244-372 induced by heparin (Fig. 2D) .
Characterization of Morphology of Human Tau Samples -Transmission electron microscopy (TEM) was used to study the morphology of human Tau samples incubated under different conditions. For wild-type Tau 244-372, the addition of DTT had no significant effect on the morphology of Tau samples, and long and branched fibrils as well as straight filaments were observed in both samples (Fig. 5A-D) , indicating that heparin could induce Tau filament formation under reducing or oxidative conditions.
DISCUSSION
Tau monomers do not assemble spontaneously under physiological conditions over experimentally tractable time periods (20) , and Tau fragments cannot assemble spontaneously to form amyloid filaments over a period of days when the concentration is lower than 150 μM (30, 31) . The pathological aggregation of Tau is a nucleation-elongation reaction that involves the formation of β-structure containing some hexapeptide motifs of the repeat domain (21) . The "driving force" for filament formation by the Tau repeat domain involves both the formation of an intermolecular disulfide bond (10) and non-covalent interactions such as hydrogen bonds, electrostatic interactions and hydrophobic interactions (17) . Then the elongation can proceed from the nuclei (10) .
In the present study, Tau filaments formed within hours when Tau fragment was incubated with heparin. Polyanionic cofactors, such as heparin and thiazine red, cause structural and conformational changes of Tau protein (17, 32, 33) , and then the kinetic and thermodynamic barriers for Tau fibrillization can be overcome (1, 34) . Although heparin is not a perfect model for HS, which coexists with Tau protein in nerve cells (12) , both heparin and HS induce formation of Tau filaments with very similar morphologies (35) . Moreover, the addition of heparin into full-length human Tau protein induces the assembly of Tau into filaments that closely resemble those observed in Alzheimer disease brain tissue (12) . Therefore, this study has implications for the putative role of endogenous HS proteoglycans in formation of NFT in Alzheimer disease. The extension of the present study of the characterization of heparin binding to human Tau fragment to the quantitative characterization of HS binding to full-length human Tau protein should lead to a better understanding of how HS proteoglycans mediate Tau filament formation in the physiological environment in Alzheimer disease brain.
So far, our experiments were conducted with human Tau fragment, but since filaments in Alzheimer disease contain full-length Tau protein it is important to demonstrate the behavior of full-length Tau bound by heparin. Human Tau fragment used in this study encompasses the four microtubule binding repeats, which does exclude a number of domains that could potentially interact with heparin. The main difference is that full-length Tau forms filaments in the presence of heparin much more slowly than Tau 244-372 induced by heparin (36) . However, we did observe straight filaments formed by Tau 244-372 induced by heparin (Fig. 5) , similar to those formed by more complete Tau proteins (12) and by full-length human Tau (Fig.  6 ) induced by heparin. Our additional ITC experiments (Fig. 7) indicated that in the absence of DTT, heparin bound to full-length human Tau protein with a moderate affinity (2.38 × 10 5 M -1
) at the first binding site followed by one weak binding event (2.80 × 10 3 M -1 ). Clearly, the binding affinity of heparin to full-length human Tau at the first binding site closely resembles that of heparin to Tau 244-372 . Based on our results and the recently published data (17), we suggest that heparin binds to full-length human Tau mainly through its segment 244-372, forming the 1:1 complex and triggering Tau fibrillization.
Neuronal cells normally have a reducing environment maintained by an excess of glutathione (1, 8) . In this study, DTT, a strong reducing agent, was used to mimic the reducing environment present in normal neuronal cells. Our data here clearly showed that at physiological pH, heparin 7K and human Tau fragment formed a tight 1:1 complex under physiological reducing conditions, triggering Tau fibrillization. High-affinity binding of heparin to Tau protein under reducing conditions provides the necessary charge compensation to allow fibril growth (17) . An oxidative (without DTT present plus air oxidation) experimental condition is closer to the physiological environment in Alzheimer disease brain (31, 37) . Our ITC data demonstrated that heparin bound to Tau fragment with a moderate binding affinity under pathological oxidative conditions, similarly triggering Tau fibrillization. Kardos and co-workers (38) have reported the first ITC study of amyloid formation, e.g. the seed-dependent extension of β 2 -microglobulin amyloid fibrils under acidic conditions. Here, we report for the first time a direct thermodynamic study of the interaction between amyloidogenic protein and inducer as well as inducer-triggered fibril formation using ITC.
Our time-dependent turbidity measurements revealed that the lag time did not vary significantly, but the apparent rate constant for the growth of fibrils increased sharply as the molar ratio of heparin to Tau increased up to 1:1 under reductive conditions, suggesting that heparin plays a regulatory role mainly in the elongation process of Tau fibrillization. When the molar ratio of heparin to Tau exceeded unity, the lag time increased and the apparent rate constant of fibril growth decreased to some extent. The retarding effect of excess heparin is attributed to a large increase in ionic strength of the medium arising from excess unbound heparin (13, 39), which was confirmed by control experiments at fixed heparin by guest on January 22, 2018 http://www.jbc.org/ Downloaded from concentrations and increasing salt concentrations (supplemental Fig. S1 ).
Based on our kinetic and thermodynamic data and the recently reported results (17, 33, 34, 39, 40) , we propose a valuable hypothesis for heparin-mediated Tau filament formation that the first step of kinetics involves binding of heparin to the natively unfolded Tau protein, forming a 1:1 complex and inducing structural and conformational changes of Tau protein, and then the nuclei are formed which is the rate-limiting step, followed by the step of fibril elongation at physiological pH (Fig. 8) . The hypothesis proposed here is different from the previous hypothesis (33) 
